Baxter International Inc.
BAX | NYSE
$22.82
+$0.02 (+0.09%)
Sep 21, 2026, 11:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 11.24B | 10.64B | 10.36B | 10.06B | 12.15B | 11.67B |
Cost of Revenue | 7.87B | 6.65B | 6.21B | 6.51B | 7.43B | 7.09B |
Gross Profit | 3.38B | 3.98B | 4.15B | 3.55B | 4.72B | 4.59B |
Operating Income | -308M | 14M | 707M | -2.85B | 1.35B | 1.62B |
Interest Income | 52M | 67M | 69M | 19M | 14M | 19M |
Pretax Income | -505M | -289M | 242M | -3.25B | 1.12B | 1.29B |
Net Income | -957M | -649M | 2.66B | -2.43B | 1.28B | 1.1B |
Selling & General & Admin | 2.89B | 2.97B | 2.95B | 3.1B | 2.85B | 2.47B |
Research & Development | 518M | 590M | 518M | 450M | 531M | 521M |
Other Expenses | 279M | 413M | -28M | 2.85B | -6M | -19M |
Operating Expenses | 3.69B | 3.97B | 3.44B | 6.39B | 3.37B | 2.97B |
Interest Expense | 290M | 408M | 508M | 413M | 207M | 153M |
Selling & Marketing Expenses | n/a | n/a | -985M | n/a | n/a | n/a |
Cost & Expenses | 11.55B | 10.62B | 9.65B | 12.9B | 10.8B | 10.06B |
Income Tax Expense | 395M | 37M | 61M | -135M | 83M | 182M |
Shares Outstanding (Basic) | 513M | 510M | 506M | 504M | 502M | 509M |
Shares Outstanding (Diluted) | 513M | 510M | 506M | 504M | 508M | 517M |
EPS (Basic) | -1.75 | -1.27 | 5.25 | -4.83 | 2.56 | 2.17 |
EPS (Diluted) | -1.75 | -1.27 | 5.23 | -4.83 | 2.53 | 2.13 |
EBITDA | 766M | 1.12B | 1.73B | -1.76B | 2.19B | 2.27B |
EBIT | -215M | 119M | 750M | -2.84B | 1.32B | 1.45B |
Depreciation & Amortization | 981M | 997M | 984M | 1.07B | 867M | 823M |
Add to Watchlist
Select watchlists to add or remove BAX